SYN-Tech Chem & Pharm Co Ltd
SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relax… Read more
SYN-Tech Chem & Pharm Co Ltd (1777) - Total Assets
Latest total assets as of December 2025: NT$2.96 Billion TWD
Based on the latest financial reports, SYN-Tech Chem & Pharm Co Ltd (1777) holds total assets worth NT$2.96 Billion TWD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
SYN-Tech Chem & Pharm Co Ltd - Total Assets Trend (2015–2025)
This chart illustrates how SYN-Tech Chem & Pharm Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
SYN-Tech Chem & Pharm Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
SYN-Tech Chem & Pharm Co Ltd's total assets of NT$2.96 Billion consist of 51.7% current assets and 48.3% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 35.4% |
| Accounts Receivable | NT$113.86 Million | 3.9% |
| Inventory | NT$340.46 Million | 11.5% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2015–2025)
This chart illustrates how SYN-Tech Chem & Pharm Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SYN-Tech Chem & Pharm Co Ltd's current assets represent 51.7% of total assets in 2025, a decrease from 66.5% in 2015.
- Cash Position: Cash and equivalents constituted 35.4% of total assets in 2025, up from 30.9% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is inventory at 11.5% of total assets.
SYN-Tech Chem & Pharm Co Ltd Competitors by Total Assets
Key competitors of SYN-Tech Chem & Pharm Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
SYN-Tech Chem & Pharm Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - SYN-Tech Chem & Pharm Co Ltd generates 0.44x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, SYN-Tech Chem & Pharm Co Ltd generates $8.84 in net profit.
SYN-Tech Chem & Pharm Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.03 | 6.08 | 2.20 |
| Quick Ratio | 3.91 | 3.78 | 1.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$1.23 Billion | NT$ 1.11 Billion | NT$ 557.39 Million |
SYN-Tech Chem & Pharm Co Ltd - Advanced Valuation Insights
This section examines the relationship between SYN-Tech Chem & Pharm Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.22 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 3.8% |
| Total Assets | NT$2.96 Billion |
| Market Capitalization | $45.13 Million USD |
Valuation Analysis
Below Book Valuation: The market values SYN-Tech Chem & Pharm Co Ltd's assets below their book value (0.02 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: SYN-Tech Chem & Pharm Co Ltd's assets grew by 3.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for SYN-Tech Chem & Pharm Co Ltd (2015–2025)
The table below shows the annual total assets of SYN-Tech Chem & Pharm Co Ltd from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | NT$2.96 Billion | +3.79% |
| 2024-12-31 | NT$2.85 Billion | -1.69% |
| 2023-12-31 | NT$2.90 Billion | +4.37% |
| 2022-12-31 | NT$2.78 Billion | -3.99% |
| 2021-12-31 | NT$2.90 Billion | +62.46% |
| 2020-12-31 | NT$1.78 Billion | -4.25% |
| 2019-12-31 | NT$1.86 Billion | +1.99% |
| 2018-12-31 | NT$1.82 Billion | +17.28% |
| 2017-12-31 | NT$1.56 Billion | +20.85% |
| 2016-12-31 | NT$1.29 Billion | +5.17% |
| 2015-12-31 | NT$1.22 Billion | -- |